ResourcesVendorsContrast MediaMRSpago NanomedicalScheelevägen 22 22363 Lund SwedeneMail:Website:https://spagonanomedical.se/en/LinkedIn iconLatest from Spago NanomedicalNuclear MedicineSpago Nanomedical moves to delist from Nasdaq First NorthBy AuntMinnieEurope.com staff writersThe move is intended to improve the company’s ability to finance further development of its Tumorad (lutetium-177 SN201) program.October 26, 2026Industry NewsSpago Nanomedical completes fundraising roundBy AuntMinnieEurope.com staff writersSpago Nanomedical recently completed its rights issue fundraising round in a rights issue, saying it will raise about 58.4 million Swedish krona (5.4 million euros) before deduction of costs.June 30, 2022Product NewsSpago readies gadolinium-free MRI agent for trialsBy AuntMinnieEurope.com staff writersSpago Nanomedical is reportedly making progress toward proof-of-concept clinical trials in 2018 for its novel gadolinium-free MRI contrast agent designed to target tumors.October 3, 2017
